Janet Abrams

1.1k total citations
17 papers, 829 citations indexed

About

Janet Abrams is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Sociology and Political Science. According to data from OpenAlex, Janet Abrams has authored 17 papers receiving a total of 829 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Pediatrics, Perinatology and Child Health and 5 papers in Sociology and Political Science. Recurrent topics in Janet Abrams's work include Cancer survivorship and care (5 papers), Family Support in Illness (4 papers) and Childhood Cancer Survivors' Quality of Life (3 papers). Janet Abrams is often cited by papers focused on Cancer survivorship and care (5 papers), Family Support in Illness (4 papers) and Childhood Cancer Survivors' Quality of Life (3 papers). Janet Abrams collaborates with scholars based in United States, United Kingdom and Czechia. Janet Abrams's co-authors include Karen L. Syrjala, Shelby L. Langer, Paul J. Martin, Barry E. Storer, Jean E. Sanders, Julia R. Heiman, Sari Roth‐Roemer, Brenda F. Kurland, Sureyya Dikmen and Samantha B. Artherholt and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Pain.

In The Last Decade

Janet Abrams

17 papers receiving 809 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Janet Abrams United States 11 413 324 247 211 126 17 829
Ellen H. Boesen Denmark 16 718 1.7× 437 1.3× 120 0.5× 131 0.6× 73 0.6× 19 971
Mel Haberman United States 12 428 1.0× 300 0.9× 118 0.5× 194 0.9× 48 0.4× 16 806
Frank Schulz‐Kindermann Germany 18 466 1.1× 346 1.1× 193 0.8× 278 1.3× 78 0.6× 41 967
Sue Burney Australia 19 407 1.0× 262 0.8× 187 0.8× 171 0.8× 47 0.4× 40 1.1k
AnnMarie Groarke Ireland 20 358 0.9× 241 0.7× 169 0.7× 88 0.4× 101 0.8× 40 978
Barry Fortner United States 22 574 1.4× 446 1.4× 82 0.3× 245 1.2× 48 0.4× 54 1.5k
Kelly A. Hyland United States 19 425 1.0× 209 0.6× 110 0.4× 159 0.8× 54 0.4× 44 852
Melissa Y. Carpentier United States 18 368 0.9× 520 1.6× 358 1.4× 174 0.8× 79 0.6× 29 1.5k
Katja I. Braam Netherlands 16 298 0.7× 707 2.2× 223 0.9× 217 1.0× 47 0.4× 26 926
Angela Scherwath Germany 17 310 0.8× 252 0.8× 102 0.4× 111 0.5× 86 0.7× 28 848

Countries citing papers authored by Janet Abrams

Since Specialization
Citations

This map shows the geographic impact of Janet Abrams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janet Abrams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janet Abrams more than expected).

Fields of papers citing papers by Janet Abrams

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janet Abrams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janet Abrams. The network helps show where Janet Abrams may publish in the future.

Co-authorship network of co-authors of Janet Abrams

This figure shows the co-authorship network connecting the top 25 collaborators of Janet Abrams. A scholar is included among the top collaborators of Janet Abrams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janet Abrams. Janet Abrams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Syrjala, Karen L., et al.. (2010). Measuring musculoskeletal symptoms in cancer survivors who receive hematopoietic cell transplantation. Journal of Cancer Survivorship. 4(3). 225–235. 18 indexed citations
2.
Syrjala, Karen L., et al.. (2009). Measuring social activities and social function in long‐term cancer survivors who received hematopoietic stem cell transplantation. Psycho-Oncology. 19(5). 462–471. 39 indexed citations
3.
Syrjala, Karen L., Janet Abrams, Nayak L. Polissar, et al.. (2008). Patient training in cancer pain management using integrated print and video materials: A multisite randomized controlled trial ☆. Pain. 135(1). 175–186. 73 indexed citations
4.
Syrjala, Karen L., Samantha B. Artherholt, Brenda F. Kurland, et al.. (2008). 47: Prospective Neurocognitive Function and Risk Factors at 5 Years After Allogeneic Hematopoietic Cell Transplantation (HCT) for Hematologic Malignancies, Compared with Controls at 5 Years. Biology of Blood and Marrow Transplantation. 14(2). 19–20. 1 indexed citations
5.
Syrjala, Karen L., Brenda F. Kurland, Janet Abrams, Jean E. Sanders, & Julia R. Heiman. (2007). Sexual function changes during the 5 years after high-dose treatment and hematopoietic cell transplantation for malignancy, with case-matched controls at 5 years. Blood. 111(3). 989–996. 80 indexed citations
6.
Abrams, Janet, et al.. (2007). Fertility and Risk Factors for Elevated Infertility Concern in 10-Year Hematopoietic Cell Transplant Survivors and Case-Matched Controls. Journal of Clinical Oncology. 25(23). 3511–3517. 59 indexed citations
7.
Syrjala, Karen L., et al.. (2005). Health-related quality of life in cancer patients with oral mucositis. Journal of Pain. 6(3). S75–S75. 1 indexed citations
8.
Syrjala, Karen L., Shelby L. Langer, Janet Abrams, Barry E. Storer, & Paul J. Martin. (2005). Late Effects of Hematopoietic Cell Transplantation Among 10-Year Adult Survivors Compared With Case-Matched Controls. Journal of Clinical Oncology. 23(27). 6596–6606. 186 indexed citations
9.
Syrjala, Karen L., Sureyya Dikmen, Shelby L. Langer, Sari Roth‐Roemer, & Janet Abrams. (2004). Neuropsychologic changes from before transplantation to 1 year in patients receiving myeloablative allogeneic hematopoietic cell transplant. Blood. 104(10). 3386–3392. 70 indexed citations
10.
Syrjala, Karen L., et al.. (2004). Physical and mental recovery after hematopoietic stem cell transplantation.. PubMed. 4(23). 263–9. 7 indexed citations
11.
Langer, Shelby L., Janet Abrams, & Karen L. Syrjala. (2003). Caregiver and patient marital satisfaction and affect following hematopoietic stem cell transplantation: a prospective, longitudinal investigation. Psycho-Oncology. 12(3). 239–253. 85 indexed citations
12.
Farnham, Shelly, et al.. (2002). HutchWorld. 375–382. 52 indexed citations
13.
Syrjala, Karen L., et al.. (2000). Sexual function measurement and outcomes in cancer survivors and matched controls. The Journal of Sex Research. 37(3). 213–225. 82 indexed citations
14.
Abrams, Janet. (1999). Strategic outlook. interactions. 6(6). 60–62. 1 indexed citations
15.
Syrjala, Karen L., Sari Roth‐Roemer, Janet Abrams, et al.. (1998). Prevalence and predictors of sexual dysfunction in long-term survivors of marrow transplantation.. Journal of Clinical Oncology. 16(9). 3148–3157. 68 indexed citations
16.
Abrams, Janet. (1995). Escape from gravity. Sight & sound/Sight and sound. 5(5). 14–19. 3 indexed citations
17.
Tchekmedyian, N. Simon, Richard Kaplan, Mario A. Eisenberger, Janet Abrams, & David Van Echo. (1987). Phase II study of N-methylformamide in patients with advanced colorectal cancer.. PubMed. 71(5). 541–2. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026